The cell-free protein synthesis (CFPS) market is set to reach USD 308.9 million by 2030, growing at a CAGR of 7.3%. Key growth drivers include rising demand for rapid protein production, adoption of ...
Preprint describes how GPT-5-driven autonomous lab significantly reduced reaction costs in cell-free protein synthesis Ginkgo ...
Ginkgo Bioworks (DNA) stock is in focus as the company as part of a collaboration with Microsoft (MSFT)-backed OpenAI cuts protein synthesis costs. Read more here.
Ginkgo Bioworks says a new AI collaboration with OpenAI is already paying off, cutting the cost of protein production in the lab by a mea ...
It had been thought that AI would play a big part in digital-only domains like math and coding, but cleverly connecting these ...
The yeast Kluyveromyces lactis (K. lactis) could become a highly productive, sustainable, cost-effective energy source for cell-free protein synthesis (CFPS) as biopharmaceutical manufacturers strive ...
In recent years, mammalian synthetic biology has made significant strides, especially in controlling gene expression and designing complex cellular behaviors. Researchers have now begun to apply these ...
An international team of scientists have used advanced microscopy to image how ribosomes recruit to mRNA. Within a cell, DNA carries the genetic code for building proteins. To build proteins, the cell ...
Viral membrane proteins are the proteins of choice in vaccines but are difficult to produce quickly and reliably for use in vaccines, limiting rapid response during emerging outbreaks. Researchers ...
Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results